These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17052808)

  • 1. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    Clin Nutr; 2006 Dec; 25(6):871-85. PubMed ID: 17052808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
    Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
    Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs: molecular targets in the pharmacogenomics era.
    Seda O; Sedová L
    Prague Med Rep; 2004; 105(3):223-36. PubMed ID: 15782550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARs and the complex journey to obesity.
    Evans RM; Barish GD; Wang YX
    Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
    Flachs P; Rossmeisl M; Bryhn M; Kopecky J
    Clin Sci (Lond); 2009 Jan; 116(1):1-16. PubMed ID: 19037880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The roles of PPAR, C/EBP and FoxO families in adipocyte differentiation and proliferation].
    Kitamura T; Kitamura Y
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():259-63. PubMed ID: 21766606
    [No Abstract]   [Full Text] [Related]  

  • 12. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
    Viana Abranches M; Esteves de Oliveira FC; Bressan J
    Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARs and their effects on the cardiovascular system.
    Oyekan A
    Clin Exp Hypertens; 2011; 33(5):287-93. PubMed ID: 21721973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines].
    Dupont J; Froment P; Ramé C; Pierre P; Coyral-Castel S; Chabrolle C
    Gynecol Obstet Fertil; 2008 Dec; 36(12):1230-8. PubMed ID: 19013096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
    Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
    Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors.
    Ferreira AM; Minarrieta L; Lamas Bervejillo M; Rubbo H
    Free Radic Biol Med; 2012 Nov; 53(9):1654-63. PubMed ID: 22982052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.